carbendazim has been researched along with Disbacteriosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, Z; Fu, Z; Jin, Y; Lou, Z; Lu, H; Wu, A; Yu, Q; Zhao, Y | 1 |
| Fu, Z; Jin, C; Jin, Y; Luo, T; Ni, Y; Wang, C; Wang, S; Zeng, Z; Zhou, J | 1 |
2 other study(ies) available for carbendazim and Disbacteriosis
| Article | Year |
|---|---|
Sub-chronic carbendazim exposure induces hepatic glycolipid metabolism disorder accompanied by gut microbiota dysbiosis in adult zebrafish (Daino rerio).
Topics: Animals; Benzimidazoles; Carbamates; Dysbiosis; Gastrointestinal Microbiome; Glycolipids; Lipid Metabolism; Male; RNA, Ribosomal, 16S; Zebrafish | 2020 |
Insights into a Possible Mechanism Underlying the Connection of Carbendazim-Induced Lipid Metabolism Disorder and Gut Microbiota Dysbiosis in Mice.
Topics: Animals; Benzimidazoles; Blood Glucose; Body Weight; Carbamates; Cytokines; Dysbiosis; Fungicides, Industrial; Gastrointestinal Microbiome; Inflammation; Insulin; Intestinal Absorption; Lipid Metabolism; Lipid Metabolism Disorders; Lipoprotein Lipase; Male; Mice; Mice, Inbred C57BL; RNA, Bacterial; Triglycerides | 2018 |